Clicky

INNATE PHARMA SP.ADR/1(IDDA) News

Date Title
Feb 17 Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
Jan 10 Innate Pharma Announces Transformative Strategy to Accelerate Growth